JAMES WACHTER: Open Payments
NPI 1396804324 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$855 in 42 payments from 12 companies in 2025. Trend: 2023 $329 · 2024 $863 · 2025 $855
Food & beverage: $855
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 12 | $190 |
| Novo Nordisk Inc | 8 | $162 |
| Medtronic, Inc. | 6 | $138 |
| Abbott Laboratories | 4 | $88 |
| SANOFI-AVENTIS U.S. LLC | 3 | $63 |
| Astellas Pharma US Inc | 3 | $62 |
| BETA BIONICS, INC. | 1 | $32 |
| Madrigal Pharmaceuticals | 1 | $31 |
| Corcept Therapeutics | 1 | $25 |
| Dexcom, Inc. | 1 | $22 |
Products named: MOUNJARO, MINIMED 780G, Ozempic, FREESTYLE LIBRE 3, TZIELD, Veozah, JARDIANCE, iLet Bionic Pancreas.
Industry payments across MD — which companies pay providers there.
